Clinical trial
Efficacy and Safety Stress Urinary Incontinence Study
NCT00475358 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00475358 |
|---|---|
| Title | Efficacy and Safety Stress Urinary Incontinence Study |
| Official title | Efficacy and Safety of Duloxetine Compared With Placebo in Subjects With Stress Urinary Incontinence |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Incontinence, Stress |
| Intervention type | Drug |
| Interventions | Duloxetine, Placebo |
| Enrollment | 120 |
| Start date | Apr 1, 2003 |
| Completion | Feb 1, 2005 |
| First posted | May 21, 2007 |
| Last update posted | May 21, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: